In primary human cancer cells harboring a variety of p53 mutations, and in organoid tumor cells bearing R248Q and R175H p53, ReACp53 reduced cytosolic p53 aggregates, facilitated p53 entry into the nucleus, and induced apoptosis in a p53 mutant-specific manner. The gene discussed is TP53; the disease is neoplasm.